The family Coriobacteriaceae is a potential contributor to the beneficial effects of Roux-en-Y gastric bypass on type 2 diabetes

Surgery for Obesity and Related Diseases

Volumn 14, Issue 5, 2018, Pages 584-593

  Liu, Haijun ^a   Zhang, Hong ^b   Wang, Xiao ^b   Yu, Xuemei ^a   Hu, Cheng ^a,b   Zhang, Xueli ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Coriobacteriaceae; Gut microbiota; Roux en Y gastric bypass; Type 2 diabetes

Indexed keywords

RNA 16S; STREPTOZOCIN;

ACTINOBACTERIA; ANIMAL EXPERIMENT; ARTICLE; ASCENDING COLON; BACTEROIDETES; CASE CONTROL STUDY; COLONOSCOPY; CONTROLLED STUDY; CORIOBACTERIACEAE; FECES MICROFLORA; FUSOBACTERIA; GENE SEQUENCE; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; INTESTINE FLORA; LIPID DIET; MALE; MICROBIAL COMMUNITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POSTOPERATIVE PERIOD; PRINCIPAL COORDINATE ANALYSIS; PRIORITY JOURNAL; PROTEOBACTERIA; ROUX-EN-Y GASTRIC BYPASS; SPRAGUE DAWLEY RAT; VERRUCOMICROBIA; ANIMAL; BLOOD; BODY WEIGHT LOSS; EXPERIMENTAL DIABETES MELLITUS; GASTRIC BYPASS SURGERY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; METABOLISM; MICROBIOLOGY; RANDOMIZATION;

ACTINOBACTERIA; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; GASTRIC BYPASS; GASTROINTESTINAL MICROBIOME; HOMEOSTASIS; MALE; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; WEIGHT LOSS;

EID: 85042066395     PISSN: 15507289     EISSN: 18787533     Source Type: Journal    
DOI: 10.1016/j.soard.2018.01.012     Document Type: Article

References (32)

1. Cavan, D., Fernandes, J.D.R., Makaroff, L., Ogurtsova, K., Webber, S., IDF diabetes atlas, 7th ed, 2015, International Diabetes Federation (IDF), Brussels.
2. Mason, E.E., History of obesity surgery. Surg Obes Relat Dis 1:2 (2005), 123–125.
3. Pories, W.J., Caro, J.F., Flickinger, E.G., Meelheim, H.D., Swanson, M.S., The control of diabetes mellitus (NIDDM) in the morbidly obese with the Greenville Gastric Bypass. Ann Surg 206:3 (1987), 316–323.
4. Mehaffey, J.H., LaPar, D.J., Clement, K.C., et al. 10-year outcomes after Roux-en-Y gastric bypass. Ann Surg 264:1 (2016), 121–126.
5. Schauer, P.R., Bhatt, D.L., Kirwan, J.P., et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med 376:7 (2017), 641–651.
6. 2. Surg Obes Relat Dis 6:4 (2010), 332–338.
7. Seeley, R.J., Chambers, A.P., Sandoval, D.A., The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes. Cell Metab 21:3 (2015), 369–378.
8. Qin, J., Li, R., Raes, J., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:7285 (2010), 59–65.
9. Lynch, S.V., Pedersen, O., The human intestinal microbiome in health and disease. N Engl J Med 375:24 (2016), 2369–2379.
10. Vrieze, A., Van Nood, E., Holleman, F., et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143:4 (2012), 913–916.
11. Murphy, R., Tsai, P., Jullig, M., Liu, A., Plank, L., Booth, M., Differential changes in gut microbiota after gastric bypass and sleeve gastrectomy bariatric surgery vary according to diabetes remission. Obes Surg 27:4 (2017), 917–925.
12. Liu, H., Hu, C., Zhang, X., Jia, W., Role of gut microbiota, bile acids and their cross-talk in the effects of bariatric surgery on obesity and type 2 diabetes. J Diabetes Invest 9:1 (2018), 13–20.
13. Guo, Y., Liu, C.Q., Shan, C.X., et al. Gut microbiota after Roux-en-Y gastric bypass and sleeve gastrectomy in a diabetic rat model: increased diversity and associations of discriminant genera with metabolic changes. Diabetes Metab Res Rev, 33(3), 2017, e2857.
14. Tremaroli, V., Karlsson, F., Werling, M., et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab 22:2 (2015), 228–238.
15. Srinivasan, K., Viswanad, B., Asrat, L., Kaul, C.L., Ramarao, P., Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 52:4 (2005), 313–320.
16. Yan, Y., Zhou, Z., Kong, F., et al. Roux-en-Y gastric bypass surgery suppresses hepatic gluconeogenesis and increases intestinal gluconeogenesis in a T2 DM rat model. Obes Surg 26:11 (2016), 2683–2690.
17. Schloss, P.D., Westcott, S.L., Ryabin, T., et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Envirn Microbiol 75:23 (2009), 7537–7541.
18. Mottawea, W., Chiang, C.K., Muhlbauer, M., et al. Altered intestinal microbiota-host mitochondria crosstalk in new onset Crohn's disease. Nature communications, 7, 2016, 13419.
19. Liou, A.P., Paziuk, M., Luevano, J.M. Jr., Machineni, S., Turnbaugh, P.J., Kaplan, L.M., Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med, 5(178), 2013, 178 ra41.
20. Kong, L.C., Tap, J., Aron-Wisnewsky, J., et al. Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes. AM J Clin Nutr 98:1 (2013), 16–24.
21. Shao, Y., Ding, R., Xu, B., et al. Alterations of gut microbiota after Roux-en-Y gastric bypass and sleeve gastrectomy in Sprague-Dawley rats. Obes Surg 27:2 (2017), 295–302.
22. Clavel, T., Lepage, P., Charrier, C., The family Coriobacteriaceae. Rosenberg, E., DeLong, E.F., Lory, S., Stackebrandt, E., Thompson, F., (eds.) The Prokaryotes: Actinobacteria, 2014, Springer, Berlin (Germany), 201–238.
23. Claus, S.P., Ellero, S.L., Berger, B., et al. Colonization-induced host-gut microbial metabolic interaction. mBio, 2(2), 2011, e00271 -10.
24. Karlsson, F.H., Tremaroli, V., Nookaew, I., et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498:7452 (2013), 99–103.
25. Qin, J., Li, Y., Cai, Z., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490:7418 (2012), 55–60.
26. Patrone, V., Vajana, E., Minuti, A., et al. Postoperative changes in fecal bacterial communities and fermentation products in obese patients undergoing bilio-intestinal bypass. Front Microbiol, 7, 2016, 200.
27. Jahansouz, C., Staley, C., Bernlohr, D.A., Sadowsky, M.J., Khoruts, A., Ikramuddin, S., Sleeve gastrectomy drives persistent shifts in the gut microbiome. Surg Obes Relat Dis 13:6 (2017), 916–924.
28. Ridlon, J.M., Kang, D.J., Hylemon, P.B., Bile salt biotransformations by human intestinal bacteria. J Lipid Res 47:2 (2006), 241–259.
29. Kuipers, F., Bloks, V.W., Groen, A.K., Beyond intestinal soap–bile acids in metabolic control. Nat Rev Endocrinol 10:8 (2014), 488–498.
30. Martínez, I., Perdicaro, D.J., Brown, A.W., et al. Diet-induced alterations of host cholesterol metabolism are likely to affect the gut microbiota composition in hamsters. Appl Environ Microbiol 79:2 (2013), 516–524.
31. Clavel, T., Desmarchelier, C., Haller, D., et al. Intestinal microbiota in metabolic diseases: from bacterial community structure and functions to species of pathophysiological relevance. Gut Microbes 5:4 (2014), 544–551.
32. Le Roy, T., Llopis, M., Lepage, P., et al. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut 62 (2013), 1787–1794.